Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
The Maudsley prescribing guidelines in psychiatry / / David Taylor, Carol Paton, Shitij Kapur
| The Maudsley prescribing guidelines in psychiatry / / David Taylor, Carol Paton, Shitij Kapur |
| Autore | Taylor David <1963-, > |
| Edizione | [12th edition.] |
| Pubbl/distr/stampa | West Sussex, England : , : Wiley Blackwell, , 2015 |
| Descrizione fisica | 1 online resource (2455 p.) |
| Disciplina | 616.89/18 |
| Soggetto topico |
Psychopharmacology
Psychotropic drugs Drugs - Prescribing |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-118-75459-X
1-118-75457-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910460261403321 |
Taylor David <1963-, >
|
||
| West Sussex, England : , : Wiley Blackwell, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Maudsley prescribing guidelines in psychiatry / / David Taylor, Carol Paton, Shitij Kapur
| The Maudsley prescribing guidelines in psychiatry / / David Taylor, Carol Paton, Shitij Kapur |
| Autore | Taylor David <1963-, > |
| Edizione | [12th edition.] |
| Pubbl/distr/stampa | West Sussex, England : , : Wiley Blackwell, , 2015 |
| Descrizione fisica | 1 online resource (2455 p.) |
| Disciplina | 616.89/18 |
| Soggetto topico |
Psychopharmacology
Psychotropic drugs Drugs - Prescribing |
| ISBN |
1-118-75459-X
1-118-75457-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910797156103321 |
|
Taylor David <1963-, >
|
||
| West Sussex, England : , : Wiley Blackwell, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Maudsley prescribing guidelines in psychiatry / / David Taylor, Carol Paton, Shitij Kapur
| The Maudsley prescribing guidelines in psychiatry / / David Taylor, Carol Paton, Shitij Kapur |
| Autore | Taylor David <1963-, > |
| Edizione | [12th edition.] |
| Pubbl/distr/stampa | West Sussex, England : , : Wiley Blackwell, , 2015 |
| Descrizione fisica | 1 online resource (2455 p.) |
| Disciplina | 616.89/18 |
| Soggetto topico |
Psychopharmacology
Psychotropic drugs Drugs - Prescribing |
| ISBN |
1-118-75459-X
1-118-75457-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910815501103321 |
|
Taylor David <1963-, >
|
||
| West Sussex, England : , : Wiley Blackwell, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Maudsley prescribing guidelines in psychiatry [[electronic resource] /] / David Taylor, Carol Paton, Shitij Kapur
| The Maudsley prescribing guidelines in psychiatry [[electronic resource] /] / David Taylor, Carol Paton, Shitij Kapur |
| Autore | Taylor David <1963-, > |
| Edizione | [11th edition.] |
| Pubbl/distr/stampa | Chichester, West Sussex, : John Wiley & Sons, 2012 |
| Descrizione fisica | 1 online resource (682 p.) |
| Disciplina | 616.89/18 |
| Altri autori (Persone) |
PatonCarol
KapurShitij TaylorDavid <1946-> |
| Soggetto topico |
Psychopharmacology - Great Britain
Psychotropic drugs - Great Britain |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-118-32325-4
0-470-97968-2 1-283-49701-8 9786613497017 0-470-97969-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
The Maudsley Prescribing Guidelines in Psychiatry; Contents; Preface; Acknowledgements; Notes on using The Maudsley Prescribing Guidelines; Notes on inclusion of drugs; List of abbreviations; Chapter 1 Plasma level monitoring of psychotropic drugs and anticonvulsants; Interpreting sample results; Chapter 2 Schizophrenia; Antipsychotic drugs; Antipsychotic drugs: equivalent doses; Antipsychotic drugs: minimum effective doses; Antipsychotic drugs: licensed maximum doses; New antipsychotic drugs; Antipsychotic drugs: general principles of prescribing
National Institute for Health and Clinical Excellence guidelines for the treatment of schizophrenia Treatment algorithms for schizophrenia; Antipsychotic drugs: monitoring of metabolic effects; Switching antipsychotic drugs because of poor tolerability; Antipsychotic response: to increase the dose, to switch, to add or just wait - what is the right move?; Speed and onset of antipsychotic drug action; First-generation antipsychotic drugs: place in therapy; Antipsychotic drugs: long-acting injections; Risperidone long-acting injection; Paliperidone palmitate long-acting injection Management of patients on long-term depots: dose reduction Combined antipsychotic drugs; High-dose antipsychotic drugs: prescribing and monitoring; Negative symptoms in schizophrenia; Antipsychotic prophylaxis; Refractory schizophrenia and clozapine; Clozapine augmentation; Refractory schizophrenia: alternatives to clozapine; Clozapine: management of common adverse effects; Clozapine: uncommon or unusual adverse effects; Clozapine: serious haematological and cardiovascular adverse effects; Clozapine, neutropenia and lithium; Clozapine and chemotherapy; Clozapine-related hypersalivation Guidelines for the initiation of clozapine for patients based in the community Omega-3 fatty acids (fish oils) in schizophrenia; Extrapyramidal side-effects of antipsychotic drug treatment; Treatment of antipsychotic-induced akathisia; Treatment of tardive dyskinesia; Neuroleptic malignant syndrome; Catatonia; Cardiovascular effects of antipsychotic drug treatment; Antipsychotic drugs and hypertension; Hyperprolactinaemia; Antipsychotic-induced weight gain; Treatment of drug-induced weight gain; Antipsychotic drugs, diabetes and impaired glucose tolerance; Antipsychotic drugs and dyslipidaemia Antipsychotic drugs and sexual dysfunction Antipsychotic-associated hyponatraemia; Antipsychotics and pneumonia; Relative adverse effects of antipsychotic drugs: a rough guide; Chapter 3 Bipolar disorder; Valproate; Lithium; Carbamazepine; Physical monitoring of people with bipolar disorder; Treatment of acute mania or hypomania; Antipsychotic drugs in bipolar disorder; Bipolar depression; Rapid cycling bipolar disorder; Prophylaxis in bipolar disorder; Chapter 4 Depression and anxiety; Depression; Antidepressants; Treatment of resistant depression; Treatment of psychotic depression Electroconvulsive therapy and psychotropic drugs |
| Record Nr. | UNINA-9910457931603321 |
|
Taylor David <1963-, >
|
||
| Chichester, West Sussex, : John Wiley & Sons, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Maudsley prescribing guidelines in psychiatry [[electronic resource] /] / David Taylor, Carol Paton, Shitij Kapur
| The Maudsley prescribing guidelines in psychiatry [[electronic resource] /] / David Taylor, Carol Paton, Shitij Kapur |
| Autore | Taylor David <1963-, > |
| Edizione | [11th edition.] |
| Pubbl/distr/stampa | Chichester, West Sussex, : John Wiley & Sons, 2012 |
| Descrizione fisica | 1 online resource (682 p.) |
| Disciplina | 616.89/18 |
| Altri autori (Persone) |
PatonCarol
KapurShitij TaylorDavid <1946-> |
| Soggetto topico |
Psychopharmacology - Great Britain
Psychotropic drugs - Great Britain |
| ISBN |
1-118-32325-4
0-470-97968-2 1-283-49701-8 9786613497017 0-470-97969-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
The Maudsley Prescribing Guidelines in Psychiatry; Contents; Preface; Acknowledgements; Notes on using The Maudsley Prescribing Guidelines; Notes on inclusion of drugs; List of abbreviations; Chapter 1 Plasma level monitoring of psychotropic drugs and anticonvulsants; Interpreting sample results; Chapter 2 Schizophrenia; Antipsychotic drugs; Antipsychotic drugs: equivalent doses; Antipsychotic drugs: minimum effective doses; Antipsychotic drugs: licensed maximum doses; New antipsychotic drugs; Antipsychotic drugs: general principles of prescribing
National Institute for Health and Clinical Excellence guidelines for the treatment of schizophrenia Treatment algorithms for schizophrenia; Antipsychotic drugs: monitoring of metabolic effects; Switching antipsychotic drugs because of poor tolerability; Antipsychotic response: to increase the dose, to switch, to add or just wait - what is the right move?; Speed and onset of antipsychotic drug action; First-generation antipsychotic drugs: place in therapy; Antipsychotic drugs: long-acting injections; Risperidone long-acting injection; Paliperidone palmitate long-acting injection Management of patients on long-term depots: dose reduction Combined antipsychotic drugs; High-dose antipsychotic drugs: prescribing and monitoring; Negative symptoms in schizophrenia; Antipsychotic prophylaxis; Refractory schizophrenia and clozapine; Clozapine augmentation; Refractory schizophrenia: alternatives to clozapine; Clozapine: management of common adverse effects; Clozapine: uncommon or unusual adverse effects; Clozapine: serious haematological and cardiovascular adverse effects; Clozapine, neutropenia and lithium; Clozapine and chemotherapy; Clozapine-related hypersalivation Guidelines for the initiation of clozapine for patients based in the community Omega-3 fatty acids (fish oils) in schizophrenia; Extrapyramidal side-effects of antipsychotic drug treatment; Treatment of antipsychotic-induced akathisia; Treatment of tardive dyskinesia; Neuroleptic malignant syndrome; Catatonia; Cardiovascular effects of antipsychotic drug treatment; Antipsychotic drugs and hypertension; Hyperprolactinaemia; Antipsychotic-induced weight gain; Treatment of drug-induced weight gain; Antipsychotic drugs, diabetes and impaired glucose tolerance; Antipsychotic drugs and dyslipidaemia Antipsychotic drugs and sexual dysfunction Antipsychotic-associated hyponatraemia; Antipsychotics and pneumonia; Relative adverse effects of antipsychotic drugs: a rough guide; Chapter 3 Bipolar disorder; Valproate; Lithium; Carbamazepine; Physical monitoring of people with bipolar disorder; Treatment of acute mania or hypomania; Antipsychotic drugs in bipolar disorder; Bipolar depression; Rapid cycling bipolar disorder; Prophylaxis in bipolar disorder; Chapter 4 Depression and anxiety; Depression; Antidepressants; Treatment of resistant depression; Treatment of psychotic depression Electroconvulsive therapy and psychotropic drugs |
| Record Nr. | UNINA-9910779093803321 |
|
Taylor David <1963-, >
|
||
| Chichester, West Sussex, : John Wiley & Sons, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Maudsley prescribing guidelines in psychiatry [[electronic resource] /] / David Taylor, Carol Paton, Shitij Kapur
| The Maudsley prescribing guidelines in psychiatry [[electronic resource] /] / David Taylor, Carol Paton, Shitij Kapur |
| Autore | Taylor David <1963-, > |
| Edizione | [11th edition.] |
| Pubbl/distr/stampa | Chichester, West Sussex, : John Wiley & Sons, 2012 |
| Descrizione fisica | 1 online resource (682 p.) |
| Disciplina | 616.89/18 |
| Altri autori (Persone) |
PatonCarol
KapurShitij TaylorDavid <1946-> |
| Soggetto topico |
Psychopharmacology - Great Britain
Psychotropic drugs - Great Britain |
| ISBN |
1-118-32325-4
0-470-97968-2 1-283-49701-8 9786613497017 0-470-97969-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
The Maudsley Prescribing Guidelines in Psychiatry; Contents; Preface; Acknowledgements; Notes on using The Maudsley Prescribing Guidelines; Notes on inclusion of drugs; List of abbreviations; Chapter 1 Plasma level monitoring of psychotropic drugs and anticonvulsants; Interpreting sample results; Chapter 2 Schizophrenia; Antipsychotic drugs; Antipsychotic drugs: equivalent doses; Antipsychotic drugs: minimum effective doses; Antipsychotic drugs: licensed maximum doses; New antipsychotic drugs; Antipsychotic drugs: general principles of prescribing
National Institute for Health and Clinical Excellence guidelines for the treatment of schizophrenia Treatment algorithms for schizophrenia; Antipsychotic drugs: monitoring of metabolic effects; Switching antipsychotic drugs because of poor tolerability; Antipsychotic response: to increase the dose, to switch, to add or just wait - what is the right move?; Speed and onset of antipsychotic drug action; First-generation antipsychotic drugs: place in therapy; Antipsychotic drugs: long-acting injections; Risperidone long-acting injection; Paliperidone palmitate long-acting injection Management of patients on long-term depots: dose reduction Combined antipsychotic drugs; High-dose antipsychotic drugs: prescribing and monitoring; Negative symptoms in schizophrenia; Antipsychotic prophylaxis; Refractory schizophrenia and clozapine; Clozapine augmentation; Refractory schizophrenia: alternatives to clozapine; Clozapine: management of common adverse effects; Clozapine: uncommon or unusual adverse effects; Clozapine: serious haematological and cardiovascular adverse effects; Clozapine, neutropenia and lithium; Clozapine and chemotherapy; Clozapine-related hypersalivation Guidelines for the initiation of clozapine for patients based in the community Omega-3 fatty acids (fish oils) in schizophrenia; Extrapyramidal side-effects of antipsychotic drug treatment; Treatment of antipsychotic-induced akathisia; Treatment of tardive dyskinesia; Neuroleptic malignant syndrome; Catatonia; Cardiovascular effects of antipsychotic drug treatment; Antipsychotic drugs and hypertension; Hyperprolactinaemia; Antipsychotic-induced weight gain; Treatment of drug-induced weight gain; Antipsychotic drugs, diabetes and impaired glucose tolerance; Antipsychotic drugs and dyslipidaemia Antipsychotic drugs and sexual dysfunction Antipsychotic-associated hyponatraemia; Antipsychotics and pneumonia; Relative adverse effects of antipsychotic drugs: a rough guide; Chapter 3 Bipolar disorder; Valproate; Lithium; Carbamazepine; Physical monitoring of people with bipolar disorder; Treatment of acute mania or hypomania; Antipsychotic drugs in bipolar disorder; Bipolar depression; Rapid cycling bipolar disorder; Prophylaxis in bipolar disorder; Chapter 4 Depression and anxiety; Depression; Antidepressants; Treatment of resistant depression; Treatment of psychotic depression Electroconvulsive therapy and psychotropic drugs |
| Record Nr. | UNINA-9910810223003321 |
|
Taylor David <1963-, >
|
||
| Chichester, West Sussex, : John Wiley & Sons, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||